• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

  • Print
  • Share
  • E-mail
  • en Español en Español

This Week in CTP - August 13, 2013

FDA Issues New Warning Letters and Updated TPSAC Meeting Information

Since the inception of the compliance and enforcement program at CTP, great strides have been made towards reducing the health burden of tobacco use on the American public.

FDA recently issued its 10,000th tobacco retailer warning letter. This milestone showcases the substantial efforts made to ensure compliance with tobacco regulations among retailers and reinforces our role in protecting public health – especially youth.

In addition, FDA recently issued warning letters to three manufacturers and one tobacco retailer for promoting or selling illegal cigarette or RYO tobacco products labeled as “pipe tobacco.” The warning letters include violations for selling modified risk tobacco products without an order in effect and/or selling prohibited flavored cigarette tobacco products.

Check out our new web feature to learn more about today’s announcement or visit the compliance and enforcement webpage for additional information. 


 This week, on August 15 and 16, FDA is hosting two meetings of the FDA Tobacco Products Scientific Advisory Committee (TPSAC).

The meeting on August 15, which will be a joint meeting with the FDA Risk Communication Advisory Committee, will focus on the results of FDA consumer research that may provide insight into how FDA can best share information with the public on harmful and potentially harmful constituents (HPHCs) in tobacco products.

On August 16, TPSAC will discuss possible approaches for evaluating information on the risks and potential benefits of a proposed modified risk tobacco product to the population as a whole.

For current information, including an updated meeting location for the August 16 meeting, visit our TPSAC webpage.